Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages

Intensive Care Medicine

Volumn 31, Issue 7, 2005, Pages 977-984

  Chang, Hung ^a   Kuo, Fu Chang ^b   Lai, Yuan Shu ^c   Chou, Tz Chong ^d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Tao Yuan Army Hospital   (Taiwan)

^c Taipei Municipal Chung Hsiao Hospital   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Cyclooxygenase 2; Cytokines; Macrophages; Perfluorochemicals; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; FC 77; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PERFLUORO COMPOUND; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; DOSE RESPONSE; DRUG EFFECT; ENZYME REPRESSION; INCUBATION TIME; INFLAMMATION; LIQUID VENTILATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; FLUOROCARBONS; LIPOPOLYSACCHARIDES; MACROPHAGES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 21744450418     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2652-y     Document Type: Article

References (25)

1. Hirschl RB, Tooley R, Parent AC, Johnson K, Barlett RH (1995) Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation. Chest 108:500-508
2. Hirschl RB, Tooley R, Parent AC, Johnson K, Barlett RH (1996) Evaluation of gas exchange, pulmonary compliance, and lung injury during total and partial liquid ventilation in the acute respiratory distress syndrome. Crit Care Med 21:1270-1278
3. Croce MA, Fabian TC, Patton JH Jr, Melton SM, Moore M, Trenthem LL (1998) Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 45:273-280
4. Smith TM, Steinhorn DM, Thusu K, Fuhrman BP, Dandona P (1995) A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med 23:1533-1539
5. Rotta AT, Gunnarsson B, Hernan LJ, Fuhrman BP, Steinhorn DM (2000) Partial liquid ventilation with perflubron attenuates in vivo oxidative damage to proteins and lipids. Crit Care Med 28:202-208
6. Thomassen MJ, Buhrow LT, Wiedemann HP (1997) Perflubron decreases inflammatory cytokine production by human alveolar macrophages. Crit Care Med 25:2045-2047
7. Jeng M-J, Kou YR, Sheu C-C, Hwang B (2002) Effects of partial liquid ventilation with FC-77 on acute lung injury in newborn piglets. Pediatr Pulmonol 33:12-21
8. 2 after trauma attenuates pro-inflammatory cytokines and improves survival. Shock 14:374-379
9. Ejima K, Layne MD, Carvajal IM, Kritek PA, Baron RM, Chen YH, Vom Saal J, Levy BD, Yet SF, Perrella MA (2003 ) Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. FASEB J 17:1325-1327
10. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144:268-271
11. 2 formation and cyclooxygenase-2 induction in lipopolysaccharide- treated RAW 264.7 macrophages. Biochem Biophys Res Commun 308:403-407
12. Martin-Sanz P, Callejas NA, Casado M, Diaz-Guerra MJ, Bosca L (1998) Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines. Br J Pharmacol 125:1313-1319
13. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384
14. 2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 93:4885-4890
15. Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G, Bertini R (2000) LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 12:1205-1210
16. Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S (2003) Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 44:2694-2701
17. Williams L, Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567-576
18. Niiro H, Otsuka T, Kuga S, Nemoto Y, Abe M, Hara N, Nakano T, Ogo T, Niho Y (1994) IL-10 inhibits prostaglandin E2 production by lipopolysaccharide- stimulated monocytes. Int Immunol 6:661-664
19. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y (2001) Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol 280:L1196-L1202
20. 2. J Exp Med 180:2365-2370
21. Nemeth ZH, Hasko G, Vizi ES (1998) Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-1alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Shock 10:49-53
22. Wu CH, Chen TL, Chen TG, Ho WP, Chiu WT, Chen RM (2003) Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages. J Trauma 55:540-545
23. Zamamiri-Davis F, Lu Y, Thompson JT, Prabhu KS, Raddy PV, Sordillo LM, Reddy CC (2002) Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 32:890-897
24. Haeberle HA, Nesti F, Dieterich H-J, Gatalica Z, Garofalo RP (2002) Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-κB activation. Am J Respir Crit Care Med 165:1433-1438
25. Gause EM, Rowlands JR (1976) Effects of fluorocarbon inhalants upon alveolar macrophages. Proc West Pharmacol Soc 19:373-380